Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
--------
Question: Paragraph: "In stark, black-and-white montages of tear-streaked female faces, District 27 state senate hopeful Kevin Rader blasts his Republican opponent in a campaign ad for her anti-abortion views. Rader, a Democrat and state House member, accuses Republican Lizbeth Benacquisto of strongly opposing abortion andhaving ties to extremist conservative groups that would criminally prosecute rape victims for having abortions. ""Lizbeth Benacquisto strongly opposes a woman's right of choice,"" the ad states. ""The extremist groups who support her would make these women into criminals. She supported an extreme law to require pregnant women to pay for and view a sonogram before they could exercise their right of choice. Her allies would make choice illegal in all cases, including rape, incest, even to save a woman's life. Vote no on Benacquisto, keep extremism out of our state Senate."" The ad enraged Benacquisto, a city councilwoman in Wellington, who responded with her own ad and therevelation that she was raped 23 years ago as a University of Florida freshman. She underscored her support for an exception to abortion for rape victims, saying she would ""never stand down when any woman has been abused,"" and demanded Rader pull the ad. Rader's camp said the only way that will happen is if Benacquisto renounces the support given to her by far-right, conservative right-to-life groups. With such a high emotion level in this campaign, we thought Rader's claim about Benacquisto's supporters was worth a look. Benacquisto is pro-life, and she makes no secret of iton her website and in questionnaires. Same with her support of the ultrasound legislation, though she has noted in various interviews she has concerns about its impact on rape victims. In a candidate questionnaire from the Christian Coalition of Florida, she added, ""I consistently support this because I am pro-life."" Benacquisto holds support from a handful of conservative, anti-abortion groups. Among those are the Christian Coalition, the Florida Right to Life PAC and the Christian Family Coalition. Though they haven't donated financially, both Florida Right to Life and the former Christian Coalition executive director have offered endorsements, and she headlined at least one event, a breakfast for the Christian Family Coalition on Oct. 16. Florida Right to Life believes life begins at conception and ends at natural death, and all points in between are to be defended. It labels abortion ""infanticide,"" which is a crime. And the Christian Coalition of Florida states, ""Although legal in the United States, we believe abortion is no less than murder of an innocent human life."" Using this logic, abortion equals murder and murder is a crime. Therefore, those who have abortions would be criminals. The Christian Family Coalition, based in Miami, says it ""works to introduce pro-family legislation at the state and local levels of government. It informs and educates citizens on where candidates stand on the issues that affect the traditional family unit."" The group's website includes a link to ""abortion,"" but contains just news articles and press releases in which it is mentioned. Each of those three organizations also closely follows abortion-related legislation. They post opinions on everything from parental notice to making the violent death of any fetus-- viable or otherwise-- cause for a first-degree murder charge. But none appear to flat-out say they would support abortion regardless of whether a woman was raped, abused by a family member or faced with death. They skirt the issue. For example, Florida Right to Life says, ""We promote, uphold and support reverence and respect for human life without regard to condition, quality, age, race, religion, color or whether born or unborn."" On the National Right to Life page, the only reference to exceptions is a 2005 survey indicating only 0.5 percent of women have abortions due to rape, while 4 percent undergo it for the mother's health. Rader's campaign manager, Michael McCall, said, ""The problem with something like that is if you take an organization like Florida Right to Life, their very core is making abortion illegal. They won't list every case in which they support banning abortions, because they support banning abortions in all cases."" It's clear that groups supporting Benacquisto have firm stands against abortion, but they're not spelled out precisely. What is clear, though, is that the groups don't offer up any exceptions. So we don't expectRader's campaign to find any." Claim: "Lizbeth Benacquisto's supporters ""would make (abortion) illegal in all cases, including rape, incest, even to save a woman's life."

Answer: "Kevin Rader says ""extremist"" supporters of his opponent would make abortion illegal in all cases"

Question: Paragraph: Mentions cost for one year of Herceptin as $40,000-$50,000. Mentions quantitative benefit of 9 weeks of Herceptin vs. no Herceptin with certain chemotherapy. Also, while no women in the Herceptin group had cardiac failure at 3 years, the follow-up period may not be long-enough to determine the effects of chemotherapy and Herceptin on the heart. Mentions potential harms of Herceptin on the heart, especially when given after certain chemotherapy. The story does not mention that there were side effects with certain chemotherapy drugs and doses needed to be decreased during the course of the trial. One aspect of this trial focused on randomization of women with Her2/neu overexpression to 9 weeks of Herceptin or no Herceptin immediately following breast cancer surgery. The drug was given in conjunction with certain types of chemotherapy, but before radiation and chemotherapy regimens known to damage the heart. The journalist states the Herceptin was given "prior to chemotherapy", which is not completely accurate. There is an adequate mention of the study design and discussion of disease-free survival at 3 years follow-up. Good job putting the results into context of other trials, and into context of how this may or may not change providers' practice. The story could have better stated the limitations of analysis for such a small subgroup 116 in each arm. Appropriately discusses the percentage of women who are eligible for Herceptin due to overexpression of HER2/neu. The story would have been helped by some context for the risk these women face. As Herceptin is used earlier and earlier these women have less to gain because they have less risk to begin with. Relative risk reductions may be very high but the absolute is not as big. Sources in addition to study authors are cited. No mention that this trial was funded in part by pharmaceutical companies. Some study investigators also receive research funding drug companies. Other doctors cited express caution about the early results of Herceptin studies, so there is some balance to the piece. The women in this trial had undergone breast cancer surgery and those with ER+ tumors were taking Tamoxifen. This is not explicitly mentioned, only that treatment took place following surgery. Still OK. Herceptin is only FDA approved to treat advanced breast cancer, but is used in clinical trials in early-stage breast cancer. This is not mentioned in the story. Novel use of Herceptin for short-term treatment prior to anthracycline chemotherapy. No evidence that this story relies on a press release. Claim: Short stint of Herceptin holds promise for breast cancer

Answer: This story discusses the results of a recent study involving women with high-risk early breast cancer (node positive or >2cm, age younger than 66 there were 25 year olds on the trial). One aspect of this trial focused on the short-term use of Herceptin with chemotherapy. Women with overexpression of the HER2/neu gene, as measured by the CISH immunohistochemistry, were randomly assigned 9 weeks of Herceptin or no Herceptin immediately following breast cancer surgery and in conjunction with certain types of chemotherapy. This regimen of treatment differed from other trials in which Herceptin was given for 12 months following chemotherapy. In this study, the drug was given in conjunction with certain types of chemotherapy, but before radiation and chemotherapy regimens known to damage the heart. The journalist states the Herceptin was given "prior to chemotherapy," which is not completely accurate. Herceptin is only FDA approved to treat advanced breast cancer, but it is used in clinical trials in early-stage breast cancer. However, this is not mentioned in the story. There is adequate discussion of the study design and reporting of disease-free survival at 3 years follow-up. There was little discussion in the piece of the side effects of chemotherapy as reported in the trial, but the addition of Herceptin was the main focus of the story. While the journalist provides quantitative benefit of 9 weeks of Herceptin vs. no Herceptin, and notes no cardiac failure in the Herceptin group, the follow-up period of 3 years may not be long-enough to determine the effects of chemotherapy and Herceptin on the heart. Overall, the journalist did a good job describing the randomization, as well as putting the results into context of other trials, and into context of how this may or may not change providers' practice. The story could have better stated the limitations of analysis for such a small subgroup (116 in each arm). The small sample randomized to Herceptin certainly warrants more study, and although the relative benefits were large, these women still had fairly good recurrence free survival 80% w/o and 90% with so although it looks like that will translate to overall survival. The question for women with overexpression of the HER/neu gene is: How much do you want to do to avoid recurrence? Sources in addition to the study investigators are cited, which provides some balance to the piece, however, there is no mention that the trial was funded in part by pharmaceutical companies. Some study investigators also receive research funding from drug companies.

Question: Paragraph: Scientists have wondered what makes these fish sing only at night. A study published on Thursday provides the answer. Laboratory experiments showed that the fish's vocalization, a low-frequency hum like a foghorn, is controlled by a light-driven internal clock and the hormone melatonin, known to govern sleep and wake cycles, researchers said. "They are among the vocal champions of the marine environment along with whales and dolphins," said Cornell University professor of neurobiology and behavior Andrew Bass. "The production and hearing of vocal signals plays a central role in their social interactions and reproductive behavior." The plainfin midshipman, up to 15 inches (38 cm) long, generally has an olive-brown color. Its name comes from rows of bioluminescent organs on its underside that reminded early observers of the buttons on a midshipman's uniform. Males migrate during the late spring and summer from deep offshore sites into shallow intertidal waters, where they build nests beneath rocky shelters. Throughout the night, they produce hums by vibrating a gas-filled bladder within their abdomen to attract females to their nests to spawn. One hum can last almost two hours. Neighboring males often hum together in a chorus. Ni Feng, who led the study in Bass' lab at Cornell and now is a Yale University postdoctoral researcher, said the study, published in the journal Current Biology, involved wild-caught fish kept in rooms where lighting could be controlled. In constant darkness, the fish hummed pretty much on schedule, thanks to their internal clock, or circadian rhythm. In constant brightness, a condition that lowers melatonin production, humming was suppressed. When kept in constant light but given a melatonin-like substitute, they continued to hum, though at random times of the day. Melatonin keeps day-active birds quiet at night and helps humans fall asleep but has the reverse effect in the midshipman fish. People have not always known what to make of the midshipman's humming. "In the early 1980s, a mysterious sound caused concern for houseboat residents of Sausalito Bay, California, who suspected the source might be the pumps of a nearby sewage plant, an underwater power line, some secret experiment by the Navy or maybe even extraterrestrials," Bass said. "It turned out their houseboats were merely resonating with the 'love songs' of male midshipman fish." Claim: Moonlight sonata: fish's nocturnal 'singing' secrets revealed.

Answer:
In one of the marvels of nature, males of a fish species called the plainfin midshipman that dwells in Pacific coastal waters from Alaska to Baja California court females during breeding season using a nocturnal "love song" with an otherworldly sound.